Sana Biotechnology, Inc.
SANA
$3.27
-$0.09-2.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.30M | 49.39M | 53.15M | 59.26M | 64.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 190.96M | 190.20M | 206.22M | 214.90M | 271.47M |
| Operating Income | -190.96M | -190.20M | -206.22M | -214.90M | -271.47M |
| Income Before Tax | -244.17M | -234.41M | -252.18M | -208.67M | -266.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -244.17 | -234.41 | -252.18 | -208.67 | -266.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -244.17M | -234.41M | -252.18M | -208.67M | -266.76M |
| EBIT | -190.96M | -190.20M | -206.22M | -214.90M | -271.47M |
| EBITDA | -178.21M | -176.70M | -191.85M | -199.49M | -255.97M |
| EPS Basic | -0.98 | -0.97 | -1.06 | -0.88 | -1.17 |
| Normalized Basic EPS | -0.45 | -0.46 | -0.52 | -0.55 | -0.72 |
| EPS Diluted | -0.98 | -0.97 | -1.06 | -0.88 | -1.17 |
| Normalized Diluted EPS | -0.45 | -0.46 | -0.52 | -0.55 | -0.72 |
| Average Basic Shares Outstanding | 1.01B | 972.78M | 947.70M | 943.73M | 923.44M |
| Average Diluted Shares Outstanding | 1.01B | 972.78M | 947.70M | 943.73M | 923.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |